Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Studies in the area of cancer gene therapy reported from S.K. Jain and co-researchers
December 30th, 2008
Data detailed in 'Development and characterization of 5-fU bearing ferritin appended solid lipid nanoparticles for tumour targeting' have been presented. "Ferritin coupled solid lipid nanoparticles were investigated for tumor targeting. Solid lipid nanoparticles were prepared using HSPC, cholesterol, DSPE and triolien," investigators in Sagar, India report. "The SLNs without ferritin which has similar lipid composition were used for comparison. SLNs preparations were characterized for shape, size and percentage entrapment. The average size of SLNs was found to be in the range 110-152 nm and maximum drug entrapment was found to be 34.6-39.1%. In vitro drug release from...
Source: Cancer Weekly (2008-12-30)
|
